Patents by Inventor John Birtles

John Birtles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug eluting expandable devices
    Patent number: 10285968
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: May 14, 2019
    Assignee: CELONOVA BIOSCIENCES, INC.
    Inventors: Richard Klein, John Birtles, John Koos, Michael J. Lee
  • DRUG ELUTING EXPANDABLE DEVICES
    Publication number: 20180200222
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 19, 2018
    Applicant: CELONOVA BIOSCIENCES, INC.
    Inventors: Richard KLEIN, John BIRTLES, John KOOS, Michael J. LEE
  • Drug eluting expandable devices
    Patent number: 9949944
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: April 24, 2018
    Assignee: CELONOVA BIOSCIENCES, INC.
    Inventors: Richard Klein, John Birtles, John Koos, Michael J. Lee
  • DRUG ELUTING EXPANDABLE DEVICES
    Publication number: 20150320910
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Inventors: Richard KLEIN, John Birtles, John Koos, Michael J. Lee
  • Drug eluting expandable devices
    Patent number: 9114125
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: August 25, 2015
    Assignee: CELONOVA BIOSCIENCES, INC.
    Inventors: Richard Klein, John Birtles, John Koos, Michael J. Lee
  • DRUG ELUTING EXPANDABLE DEVICES
    Publication number: 20090258049
    Abstract: The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
    Type: Application
    Filed: April 11, 2008
    Publication date: October 15, 2009
    Inventors: Richard Klein, John Birtles, John Koos, Michael J. Lee